扫码关注公众号           扫码咨询技术支持           扫码咨询技术服务
  
客服热线:400-901-9800  客服QQ:4009019800  技术答疑  技术支持  质量反馈  人才招聘  关于我们  联系我们
【2月文献战报】Bioss抗体新增高分文献精彩呈现-北京博奥森生物技术有限公司
首页 > 新闻动态 > 正文
【2月文献战报】Bioss抗体新增高分文献精彩呈现
发表者:北京博奥森生物      发表时间:2023-5-16



截止目前,引用Bioss产品发表的文献共24403篇总影响因子113884.3分,发表在Nature, Science, Cell以及Immunity等顶级期刊的文献共57篇,合作单位覆盖了清华、北大、复旦、华盛顿大学、麻省理工学院、东京大学以及纽约大学等国际知名研究机构上百所。

我们每月收集引用Bioss产品发表的文献。若您在当月已发表SCI文章,但未被我公司收集,请致电Bioss,我们将赠予现金鼓励,金额标准请参考“发文章 领奖金”活动页面。

近期收录2023年2月引用Bioss产品发表的文献共301篇(图一,绿色柱),文章影响因子(IF) 总和高达1903.359,其中,10分以上文献30篇(图二)。

图一


图二



本文主要分享引用Bioss产品发表文章至Nature NanotechnologyImmunityCancer Cell等期刊的5篇 IF>15 的文献摘要让我们一起欣赏吧。


IMMUNITY [IF=43.474]

文献引用抗体:bs-10162R

Anti-ALDH1A1 pAb | WB

作者单位:中国科学院动物模型与人类疾病机制重点实验室

摘要:Monoamine insufficiency is suggested to be associated with depressive features such as sadness, anhedonia, insomnia, and cognitive dysfunction, but the mechanisms that cause it are unclear. We found that the acute-phase protein lipopolysaccharide-binding protein (LBP) inhibits monoamine biosynthesis by acting as an endogenous inhibitor of dopamine-β-hydroxylase (DBH) and aromatic-L-amino-acid-decarboxylase (DDC). LBP expression was increased in individuals with depression and by diverse stress challenges in mice. LBP antibodies and LBP knockdown inhibited monoamine insufficiency and depression-like features in mice, which worsened with LBP overexpression or administration. Monoamine insufficiency and depression-like symptoms were not induced by stressful stimuli in LBP-deficient mice, further highlighting a role for LBP in stress-induced depression, and a peptide we designed that blocks LBP-DBH and LBP-DDC interactions showed anti-depression effects in mice. This study reveals an important role for LBP in regulating monoamine biosynthesis and suggests that targeting LBP may have potential as a treatment for some individuals with depression.


BRAIN BEHAVIOR AND IMMUNITY  [IF=19.227]

文献引用抗体:

bs-0061RAnti-beta-Actin (Loading Control) pAb | WB

bs-4511RAnti-Beta tubulin (Loading Control) pAb | WB

bs-0295G-AF555Goat Anti-Rabbit IgG H&L / AF555 | IF
作者单位:青岛大学神经再生与神经康复研究所

摘要:Acyl-CoA synthetase long-chain family member4 (ACSL4) is an important isozyme in polyunsaturated fatty acid (PUFA) metabolism. The role of ACSL4 in the lipopolysaccharide (LPS)-induced inflammation of microglia, and the effects of ACSL4-mediated inflammation on the progression of Parkinson’s disease (PD) are unknown. In this study, we found that ACSL4 expression was increased after LPS stimulation. Knocking down ACSL4 in microglia decreased proinflammatory cytokine production. Mechanistically, ACSL4 reduced vestigial-like family member 4 (VGLL4) expression to promote NF-κB signal transduction; and ACSL4 regulated lipid composition after LPS stimulation. In addition, knocking down ACSL4 alleviated neuroinflammation in a systemic LPS model and acute l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP) model. These data revealed ACSL4 to be a novel regulator that promotes microglia-mediated neuroinflammation by regulating VGLL4 expression and lipid metabolism.


Nature Communications  [IF=17.694]

文献引用抗体:bs-2962R

Anti-Syncytin 1 pAb | WB

作者单位:美国贝塞斯达国立卫生研究院尤尼斯·肯尼迪·施莱佛国立儿童健康和人类发展研究所膜生物学分部

摘要:Multinucleated osteoclasts, essential for skeletal remodeling in health and disease, are formed by the fusion of osteoclast precursors, where each fusion event raises their bone-resorbing activity. Here we show that the nuclear RNA chaperone, La protein has an additional function as an osteoclast fusion regulator. Monocyte-to-osteoclast differentiation starts with a drastic decrease in La levels. As fusion begins, La reappears as a low molecular weight species at the osteoclast surface, where it promotes fusion. La’s role in promoting osteoclast fusion is independent of canonical La-RNA interactions and involves direct interactions between La and Annexin A5, which anchors La to transiently exposed phosphatidylserine at the surface of fusing osteoclasts. Disappearance of cell-surface La, and the return of full length La to the nuclei of mature, multinucleated osteoclasts, acts as an off switch of their fusion activity. Targeting surface La in a novel explant model of fibrous dysplasia inhibits excessive osteoclast formation characteristic of this disease, highlighting La’s potential as a therapeutic target.


Nature Communications  [IF=17.694]


文献引用抗体:bs-1061R

Anti-MPO pAb | IHC

作者单位:山东大学齐鲁医学院药学系,NMPA药物产品技术研究和评价重点实验室和化学生物学重点实验室

摘要:Massive intra-articular infiltration of proinflammatory macrophages is a prominent feature of rheumatoid arthritis (RA) lesions, which are thought to underlie articular immune dysfunction, severe synovitis and ultimately joint erosion. Here we report an efferocytosis-informed nanoimitator (EINI) for in situ targeted reprogramming of synovial inflammatory macrophages (SIMs) that thwarts their autoimmune attack and reestablishes articular immune homeostasis, which mitigates RA. The EINI consists of a drug-based core with an oxidative stress-responsive phosphatidylserine (PtdSer) corona and a shell composed of a P-selectin-blocking motif, low molecular weight heparin (LMWH). When systemically administered, the LMWH on the EINI first binds to P-selectin overexpressed on the endothelium in subsynovial capillaries, which functions as an antagonist, disrupting neutrophil synovial trafficking. Due to the strong dysregulation of the synovial microvasculature, the EINI is subsequently enriched in the joint synovium where the shell is disassembled upon the reactive oxygen species stimulation, and PtdSer corona is then exposed. In an efferocytosis-like manner, the PtdSer-coroneted core is in turn phagocytosed by SIMs, which synergistically terminate SIM-initiated pathological cascades and serially reestablish intra-articular immune homeostasis, conferring a chondroprotective effect. These findings demonstrate that SIMs can be precisely remodeled via the efferocytosis-mimetic strategy, which holds potential for RA treatment.


Advanced Science [IF=17.521]

文献引用抗体:

bs-0465RAnti-NFKB p65 pAb | WB

bs-0982RAnti-phospho-NFKB p65 (Ser536) pAb | WB

bs-1194RAnti-NFkB1 pAb | WB

bs-0637RAnti-P38 MAPK pAb | WB

bs-0636RAnti-Phospho-P38 MAPK (Thr180 + Tyr182) pAb | WB

bs-1047RAnti-MyD88 pAb | WB

bsm-52239RAnti-STAT6 mAb | WB

作者单位:北京大学药学院分子药剂学与新药传递系统重点实验室

摘要:Osteoarthritis (OA) is a progressive joint disease characterized by inflammation and cartilage destruction, and its progression is closely related to imbalances in the M1/M2 synovial macrophages. A two-pronged strategy for the regulation of intracellular/extracellular nitric oxide (NO) and hydrogen protons for reprogramming M1/M2 synovial macrophages is proposed. The combination of carbonic anhydrase IX (CA9) siRNA and NO scavenger in “two-in-one” nanocarriers (NAHA-CaP/siRNA nanoparticles) is developed for progressive OA therapy by scavenging NO and inhibiting CA9 expression in synovial macrophages. In vitro experiments demonstrate that these NPs can significantly scavenge intracellular NO similar to the levels as those in the normal group and downregulate the expression levels of CA9 mRNA (≈90%), thereby repolarizing the M1 macrophages into the M2 phenotype and increasing the expression levels of pro-chondrogenic TGF-β1 mRNA (≈1.3-fold), and inhibiting chondrocyte apoptosis. Furthermore, in vivo experiments show that the NPs have great anti-inflammation, cartilage protection and repair effects, thereby effectively alleviating OA progression in both monoiodoacetic acid-induced early and late OA mouse models and a surgical destabilization of medial meniscus-induced OA rat model. Therefore, the siCA9 and NO scavenger “two-in-one” delivery system is a potential and efficient strategy for progressive OA treatment.

※ 点击这里查看往期单月Bioss抗体产品文献引用列表
版权所有 2004-2026 www.bioss.com.cn 北京博奥森生物技术有限公司
通过国际质量管理体系ISO 9001:2015 GB/T 19001-2016    认证编号: 00122Q31509R1M/1100
京ICP备05066980号-1         京公网安备110107000727号